WallStreetZen

NYSE: LLY
ELI LILLY & Co Earnings & Revenue

LLY past earnings growth

How has LLY's earnings growth performed historically?
Company
6.83%
Industry
22.33%
Market
96.23%
LLY's earnings have grown faster (23.14% per year) than the US Drug Manufacturers - General industry average (11.67%)
Performance
LLY's earnings have grown slower (23.14% per year) than the US market average (33.21%)
Performance
LLY's earnings growth is slowing down - its growth over the last year (6.83%) is below its 5-year compound annual rate (23.14%)
Performance

LLY past revenue growth

How has LLY's revenue growth performed historically?
Company
19.58%
Industry
18.11%
Market
42.59%
LLY's revenue has grown faster (5.9% per year) than the US Drug Manufacturers - General industry average (5.44%)
Performance
LLY's revenue has grown slower (5.9% per year) than the US market average (19.59%)
Performance
LLY's revenue growth is accelerating - its growth over the last year (19.58%) is above its 5-year compound annual rate (5.9%)
Performance

LLY earnings and revenue history

Current Revenue
$27.8B
Current Earnings
$6.0B
Current Profit Margin
21.5%
LLY's has not demonstrated consistent long-term earnings growth over the past 10 years (57.18%)
Performance

LLY Return on equity

Current Company
89.3%
Current Industry
50.7%
Current Market
21.6%
LLY's Return on Equity (89.3%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance

LLY Return on assets

Current Company
12.6%
Current Industry
8.3%
LLY is generating higher Return on Assets (12.6%) than the US Drug Manufacturers - General industry average (7.57%)
Performance

LLY Return on capital employed

Current Company
19.66%
Current Industry
12.5%
LLY has gotten more efficient at generating Return on Capital (19.66%) compared to 3 years ago (9.17%)
Performance

ELI LILLY & Earnings & Revenue FAQ

What were LLY's earnings last quarter?

On Invalid Date, ELI LILLY & (NYSE: LLY) reported Q3 2021 earnings per share (EPS) of $1.22, up 8.27% year over year. Total ELI LILLY & earnings for the quarter were $1.11 billion. In the same quarter last year, ELI LILLY &'s earnings per share (EPS) was $1.33.

What was LLY's earnings growth in the past year?

As of Q4 2021, ELI LILLY &'s earnings has grown 6.83% year over year. This is 15.5 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 22.33%. ELI LILLY &'s earnings in the past year totalled $5.97 billion.

What was LLY's revenue last quarter?

On Invalid Date, ELI LILLY & (NYSE: LLY) reported Q3 2021 revenue of $6.77 billion up 17.98% year over year. In the same quarter last year, ELI LILLY &'s revenue was $5.74 billion.

What was LLY's revenue growth in the past year?

As of Q4 2021, ELI LILLY &'s revenue has grown 19.58% year over year. This is 1.47 percentage points higher than the US Drug Manufacturers - General industry revenue growth rate of 18.11%. ELI LILLY &'s revenue in the past year totalled $27.76 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.